Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Calverley

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
The New England Journal of Medicine|September 3, 2013
Tiotropium Respimat inhaler and the risk of death in COPDRobert A Wise, Antonio Anzueto, Daniel Cotton, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2007
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryKlaus F Rabe, Suzanne Hurd, Antonio Anzueto, et al.
BMJ Open Respiratory Research|July 2, 2019
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trialBartolome R Celli, Julie A Anderson, Robert Brook, et al.
Trials|January 15, 2016
The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trialLisa Loughney, Malcolm A West, Graham J Kemp, et al.
Annals of the American Thoracic Society|September 17, 2025
Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY CohortRichard Beasley, Rod Hughes, Alvar Agusti, et al.
The New England Journal of Medicine|September 17, 2010
Susceptibility to exacerbation in chronic obstructive pulmonary diseaseJohn R Hurst, Jørgen Vestbo, Antonio Anzueto, et al.
COPD|April 4, 2013
COPD causation and workplace exposures: an assessment of agreement among expert clinical ratersDavid Fishwick, Anthony Darby, Eva Hnizdo, et al.
Thorax|June 15, 2012
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseasePaul Albert, Alvar Agusti, Lisa Edwards, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2012
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseBartolome R Celli, Nicholas Locantore, Julie Yates, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2024
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?Daniel C Belz, Nirupama Putcha, Patricia Alupo, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|September 3, 2013
Tiotropium Respimat inhaler and the risk of death in COPDRobert A Wise, Antonio Anzueto, Daniel Cotton, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2007
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryKlaus F Rabe, Suzanne Hurd, Antonio Anzueto, et al.
BMJ Open Respiratory Research|July 2, 2019
Serum biomarkers and outcomes in patients with moderate COPD: a substudy of the randomised SUMMIT trialBartolome R Celli, Julie A Anderson, Robert Brook, et al.
Trials|January 15, 2016
The effects of neoadjuvant chemoradiotherapy and an in-hospital exercise training programme on physical fitness and quality of life in locally advanced rectal cancer patients (The EMPOWER Trial): study protocol for a randomised controlled trialLisa Loughney, Malcolm A West, Graham J Kemp, et al.
Annals of the American Thoracic Society|September 17, 2025
Prevalence and Clinical Characteristics of Persistent Airflow Limitation in the NOVELTY CohortRichard Beasley, Rod Hughes, Alvar Agusti, et al.
The New England Journal of Medicine|September 17, 2010
Susceptibility to exacerbation in chronic obstructive pulmonary diseaseJohn R Hurst, Jørgen Vestbo, Antonio Anzueto, et al.
COPD|April 4, 2013
COPD causation and workplace exposures: an assessment of agreement among expert clinical ratersDavid Fishwick, Anthony Darby, Eva Hnizdo, et al.
Thorax|June 15, 2012
Bronchodilator responsiveness as a phenotypic characteristic of established chronic obstructive pulmonary diseasePaul Albert, Alvar Agusti, Lisa Edwards, et al.
American Journal of Respiratory and Critical Care Medicine|March 20, 2012
Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary diseaseBartolome R Celli, Nicholas Locantore, Julie Yates, et al.
American Journal of Respiratory and Critical Care Medicine|October 15, 2024
Call to Action: How Can We Promote the Development of New Pharmacologic Treatments in Chronic Obstructive Pulmonary Disease?Daniel C Belz, Nirupama Putcha, Patricia Alupo, et al.
Pageof 6